- Report
- February 2025
- 200 Pages
Global
From €4092EUR$4,490USD£3,495GBP
- Report
- August 2024
- 164 Pages
Global
From €4552EUR$4,995USD£3,888GBP
- Report
- February 2023
- 198 Pages
Global
From €6835EUR$7,500USD£5,838GBP
- Report
- January 2024
- 200 Pages
Global
From €3782EUR$4,150USD£3,230GBP
- Report
- April 2025
- 227 Pages
China
From €3645EUR$4,000USD£3,114GBP
- Report
- April 2025
- 114 Pages
China
From €1640EUR$1,800USD£1,401GBP
- Report
- April 2025
- 50 Pages
Global
From €2415EUR$2,650USD£2,063GBP
Triazolam is a benzodiazepine drug used to treat insomnia and anxiety. It is classified as a central nervous system (CNS) depressant, and is used to reduce the time it takes to fall asleep and to increase the duration of sleep. Triazolam is a short-acting drug, meaning its effects last for a short period of time. It is usually taken as a single dose at bedtime. Common side effects of triazolam include drowsiness, dizziness, and confusion.
Triazolam is one of many CNS drugs used to treat insomnia and anxiety. Other drugs in this class include benzodiazepines, barbiturates, and non-benzodiazepines. These drugs work by increasing the activity of the neurotransmitter GABA, which helps to reduce anxiety and induce sleep.
Some companies in the triazolam market include Pfizer, Mylan, and Sandoz. Show Less Read more
